INTS (STOCKS)
Intensity Therapeutics, Inc. Common stock
$4.012000
-0.148000 (-3.56%)
Prev close: $4.160000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Lewis H. Bender
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $12.85M
- Employees
- 16
- P/E (TTM)
- -0.86
- P/B (TTM)
- 1.33
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $11.48M |
| Research and Development | $6.08M |
| Other Operating Expenses | $5.40M |
| Operating Income/Loss | -$11.48M |
| Income/Loss From Continuing Operations After Tax | -$11.16M |
| Income/Loss From Continuing Operations Before Tax | -$11.16M |
| Net Income/Loss | -$11.16M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.16M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.16M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$10.37 |
| Diluted Earnings Per Share | -$10.37 |
| Basic Average Shares | 21,223,033 |
| Diluted Average Shares | 21,223,033 |
| Assets | $11.52M |
| Current Assets | $11.23M |
| Cash | $9.50M |
| Prepaid Expenses | $1.70M |
| Other Current Assets | $29.00K |
| Noncurrent Assets | $292.00K |
| Liabilities | $2.31M |
| Current Liabilities | $2.25M |
| Accounts Payable | $1.01M |
| Wages | $269.00K |
| Other Current Liabilities | $967.00K |
| Noncurrent Liabilities | $62.00K |
| Equity | $9.21M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.21M |
| Liabilities And Equity | $11.52M |
| Net Cash Flow From Operating Activities | -$8.95M |
| Net Cash Flow From Operating Activities, Continuing | -$8.95M |
| Net Cash Flow From Investing Activities | -$7.31M |
| Net Cash Flow From Investing Activities, Continuing | -$7.31M |
| Net Cash Flow From Financing Activities | $16.27M |
| Net Cash Flow From Financing Activities, Continuing | $16.27M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$11.16M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.16M |
| Other Comprehensive Income/Loss | $0.00 |